Recent Updates
Recently added Catalysts
CRSP

CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit

Key Takeaway: CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit
Price reaction · baseline $79.04 (2024-02-14 close) · hit after-hours · 1 other CRSP headline(s) in the window, move may be shared
day 0 close · peak
+6.9%
day 1
+4%
day 3
+4.3%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension

Full Press Release Details

CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit.
Last updated: Feb 15, 2024